Chemoinformaics analysis of 3-(4-Hydroxy-3-methoxy-phenyl)-acrylic acid octahydro-quinolizin-1-ylmethyl ester
| Molecular Weight | 345.439 | nRot | 5 |
| Heavy Atom Molecular Weight | 318.223 | nRig | 19 |
| Exact Molecular Weight | 345.194 | nRing | 3 |
| Solubility: LogS | -3.623 | nHRing | 2 |
| Solubility: LogP | 3.782 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 27 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 55.7114 |
| nHD | 1 | BPOL | 33.1366 |
| QED | 0.656 |
| Synth | 3.069 |
| Natural Product Likeliness | 0.731 |
| NR-PPAR-gamma | 0.062 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.089 |
| Pgp-sub | 0.848 |
| HIA | 0.012 |
| CACO-2 | -4.862 |
| MDCK | 0.0000418 |
| BBB | 0.851 |
| PPB | 0.790542 |
| VDSS | 1.811 |
| FU | 0.168438 |
| CYP1A2-inh | 0.134 |
| CYP1A2-sub | 0.894 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.855 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.117 |
| CYP2d6-inh | 0.981 |
| CYP2d6-sub | 0.912 |
| CYP3a4-inh | 0.057 |
| CYP3a4-sub | 0.507 |
| CL | 11.567 |
| T12 | 0.853 |
| hERG | 0.748 |
| Ames | 0.074 |
| ROA | 0.297 |
| SkinSen | 0.961 |
| Carcinogencity | 0.636 |
| EI | 0.053 |
| Respiratory | 0.939 |
| NR-Aromatase | 0.501 |
| Antiviral | Yes |
| Prediction | 0.812108 |